Beckman Coulter, Inc. (NYSE:BEC) will hold its Annual Business Review in New York City on Thursday, December 17. The event will run from 2:30 pm to 5:00 pm ET. Hosting will be Beckman Coulter Chairman, President and Chief Executive Officer Scott Garrett, and Chief Financial Officer Charlie Slacik. Interested parties may listen to the meeting via webcast on the company’s website, http://www.beckmancoulter.com/. The webcast will be under “What’s Ahead” on the “go to IR” page of the “Investor Relations section.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Beckman Coulter, Inc. is a manufacturer and marketer of biomedical testing instrument systems, tests and supplies. The products of the categories falls in two categories: clinical diagnostics, and life science research instruments and tools. The clinical diagnostics are found in the hospitals and other critical care settings globally and produce information produced by laboratory-based testing. Clinical Diagnostic customers include hospitals, physician’s offices and reference laboratories. The life science research instruments and tools are used by scientists to study biological problems, including the causes of disease, to identify new therapies and to test new drugs. The Company operates in two business segments: Clinical Diagnostics and Life Science. In April 2009, the Company acquired Cogenics from Clinical Data, Inc. In August 2009, it acquired Olympus' lab-based diagnostics business. In August 2009, the Company announced the creation of Beckman Coulter Genomics.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
